StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
4
Publishing Date
2022 - 08 - 09
1
2022 - 03 - 31
1
2022 - 01 - 31
1
2021 - 10 - 28
1
Sector
Health technology
4
Tags
100
3
Acquire
1
Acquisition
2
Acquisition corp
1
Als
9
Application
4
Approval
9
Berubicin
24
Biopharma
1
Biotech-bay
1
Ces
5
Change
1
Commercial
1
Companies
2
Company announcement
3
Conference
7
Covid-19
1
Deadline
7
Designation
5
Disease
4
Drug
5
Earnings
6
Europe
2
Events
3
Fast track
3
Fast track designation
2
Fda
12
Fda-approvals
2
Financial
4
Financial results
9
Friedreich's ataxia
2
Friedreich’s ataxia
6
Glioblastoma
13
Global
6
Growth
2
Kidney
4
Lone-star-bio
26
Market
2
N/a
48
Offering
4
Ongoing
10
People
3
Pharmaceuticals
21
Potential
14
Presentation
5
Program
3
Regulatory
3
Report
3
Research
5
Results
17
Review
2
Skyclarys
2
Study
7
Submission
3
Switzerland
3
Syndros
4
Therapeutics
2
Treatment
28
Trial
11
Update
6
Entities
Reata pharmaceuticals, inc.
4
Symbols
AAPL
18
ABB
20
ABBV
15
ABLZF
18
ABT
20
ACN
18
AKAM
12
ALNY
12
ALPMF
18
ALPMY
18
AMCR
10
AMGN
12
ARVL
10
AVGO
28
BDX
19
BGNE
10
BIIB
23
BKYI
10
BMY
22
CALT
11
CRM
24
CSCO
16
DHR
15
EMN
13
ERIC
20
FNCTF
36
GE
12
GOOG
23
GOOGL
23
GTCH
10
HON
30
IBM
14
IFNNF
12
IFNNY
11
INCY
17
INTC
16
IT
20
JAGX
11
JNJ
39
LLY
19
LMT
10
MDT
15
MMM
21
MRK
11
MSFT
37
NOC
10
NVS
12
ORCL
33
PFE
24
PHG
15
RDWR
26
SAP
54
SAPGF
30
SNPS
10
SNY
44
SNYNF
37
STM
10
TAK
11
TEVJF
11
TMO
29
Exchanges
Nasdaq
4
Crawled Date
2022 - 08 - 09
1
2022 - 03 - 31
1
2022 - 01 - 31
1
2021 - 10 - 28
1
Crawled Time
11:00
1
15:30
1
21:00
1
22:00
1
Source
www.biospace.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Application
symbols :
RETA
save search
Reata Pharmaceuticals Announces Three Month Extension of the Review Period for New Drug Application for Omaveloxolone for the Treatment of Friedreich’s Ataxia
Published:
2022-08-09
(Crawled : 11:00)
- biospace.com/
RETA
|
$172.36
0.02%
0.03%
0
|
Health Technology
|
616.38%
|
O:
-1.21%
H:
0.13%
C:
-10.18%
treatment
drug
extension
application
review
friedreich’s ataxia
Reata Pharmaceuticals Completes Rolling Submission of New Drug Application for Omaveloxolone for the Treatment of Patients with Friedreich’s Ataxia
Published:
2022-03-31
(Crawled : 22:00)
- biospace.com/
RETA
|
$172.36
0.02%
0.03%
0
|
Health Technology
|
458.16%
|
O:
2.04%
H:
6.09%
C:
3.97%
treatment
drug
application
submission
friedreich’s ataxia
Reata Pharmaceuticals Initiates Rolling Submission of New Drug Application with U.S. FDA for Omaveloxolone for the Treatment of Patients with Friedreich’s Ataxia
Published:
2022-01-31
(Crawled : 15:30)
- biospace.com/
RETA
|
$172.36
0.02%
0.03%
0
|
Health Technology
|
592.21%
|
O:
1.0%
H:
13.68%
C:
11.81%
new drug
treatment
fda
als
application
drug
one
submission
friedreich's ataxia
friedreich’s ataxia
Reata Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Bardoxolone Methyl in Chronic Kidney Disease Caused by Alport Syndrome
Published:
2021-10-28
(Crawled : 21:00)
- biospace.com/
RETA
|
$172.36
0.02%
0.03%
0
|
Health Technology
|
79.39%
|
O:
0.23%
H:
3.98%
C:
0.03%
disease
europe
application
kidney
syndros
Gainers vs Losers
61%
39%
Top 10 Gainers
BOF
|
$2.08
77.78%
39.06%
110M
|
BHIL
|
$0.1793
-4.37%
19.24%
340K
|
Agriculture, Forestry, Fishing ...
UMAC
|
$1.48
-1.33%
14.87%
20K
|
CI
|
$352.28
-0.11%
13.53%
2
|
Health Services
CIG.C
|
$2.89
-1.37%
12.8%
2.3K
|
n/a
MTH
|
$154.69
-2.21%
12.68%
450K
|
Consumer Durables
HCP
|
News
|
$31.41
7.75%
11.26%
1.2M
|
BMTX
4
|
$1.545
0.98%
10.03%
2.5K
|
Information
TAL
|
$12.26
0.57%
9.22%
12M
|
Consumer Services
ASXC
|
$0.243
-2.41%
7.0%
1.1M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.